Company Legal Name
Latest Valuation
Founded Year
Headquarter
Nabla Technologies develops an ambient AI assistant that automatically generates clinical notes during patient visits, enabling healthcare providers to focus on patient care rather than documentation. The Paris-based company, founded in 2018, operates in the rapidly growing AI medical scribes market, addressing the critical pain point of administrative burden in healthcare settings. Nabla's solution uses advanced natural language processing to capture and transcribe patient encounters in real-time, streamlining clinical workflows and reducing physician burnout. The company continues to expand its AI capabilities and market presence, targeting healthcare systems seeking to improve operational efficiency while enhancing patient-provider interactions.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





